Cracking the Ketamine Code

NIMH supported science and NIMH researchers helped pave the way for the development of ketamine—a groundbreaking treatment that has improved the lives of those who are impacted by treatment-resistant depression.

from NIMH News Feed https://ift.tt/ja37QOS

Read More

Facebook Live: Childhood Irritability

NIMH is hosting a Facebook Live event on childhood irritability featuring NIMH expert Dr. Melissa Brotman, chief of the Neuroscience and Novel Therapeutics Unit in the Intramural Research Program.

from NIMH News Feed https://ift.tt/YFzr5oN

Read More

Helping People With Serious Mental Illness Quit Smoking

In a study funded by the National Institute of Mental Health and published in JAMA Psychiatry, Gail Daumit, M.D., of Johns Hopkins University, A. Eden Evins, M.D., of Massachusetts General Hospital and Harvard Medical School, and colleagues developed a tobacco smoking cessation intervention for people with serious mental illness.

from NIMH News Feed https://ift.tt/lKx8Sms

Read More

2023 Global Mental Health Conference: Research Without Borders

The 12th Global Mental Health Research Without Borders Conference brings together researchers, innovators, and scholars from around the globe to highlight cutting-edge findings and explore new opportunities for groundbreaking research.

from NIMH News Feed https://ift.tt/iqZW7G9

Read More

Technical Assistance Webinar: The Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes

This technical assistance webinar is for prospective applicants of the Notice of Funding Opportunity: The Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes.

from NIMH News Feed https://ift.tt/i58FUJn

Read More

Scientists Unveil Detailed Cell Maps of the Human Brain and the Nonhuman Primate Brain

A group of international scientists have mapped the genetic, cellular, and structural makeup of the human brain and the nonhuman primate brain, allowing for a deeper knowledge of the cellular basis of brain function and dysfunction, helping pave the way for a new generation of precision therapeutics for people with mental disorders and other disorders of the brain.

from NIMH News Feed https://ift.tt/szZAm2l

Read More

2023 NIMH James S. Jackson Memorial Award Lecture: The Critical Health Equity Imperative: Five Insights About Reducing Health Inequities from my Research with U.S. Black LGB People and Heterosexual Men

The winner of the 2023 James S. Jackson Memorial Award, Lisa Bowleg, Ph.D., M.A. will discuss her research on reducing health inequities.

from NIMH News Feed https://ift.tt/aNbhDfQ

Read More

Technical Assistance Webinar: Approaches to Identifying Preteen Suicide Risk and Protective Factors

This technical assistance webinar was held for prospective applicants of the following Notice of Funding Opportunities (NOFOs): Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed) and Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed).

from NIMH News Feed https://ift.tt/WLY5Zxh

Read More

Depression: The Case for Ketamine

Ketamine. For some people with treatment-resistant depression, this experimental therapy proved to be more than just life-changing—it was lifesaving. But how did a drug once used as a battlefield anesthetic evolve into esketamine, a treatment for major depressive illnesses? In this episode, we'll talk with Dr. Carlos Zarate Jr., who helped lay the groundwork for esketamine for treatment-resistant depression. We'll learn the history behind the development of esketamine, how it can help with depression, and what the future holds for this innovative line of clinical research.

from NIMH News Feed https://ift.tt/L0v3NU8

Read More